Erudio Healtherudio.com
Clinical trial · no report yet · Phase 3
CANOPY-A
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
- NCT03447769 ↗
- Terminated
- Novartis Pharmaceuticals
- Focused
We haven't built an HCP commentary report on CANOPY-A (canakinumab) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on CANOPY-A so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 7 | |
| YouTube | 1 |
The trial
ClinicalTrials.gov- Official title
- A Phase III, Multicenter, Randomized, Double Blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Canakinumab Versus Placebo as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II -IIIA and IIIB (T>5cm N2) Completely Resected (R0) Non-small Cell Lung Cancer (NSCLC)
- Phase
- Phase 3
- Status
- Terminated
- Conditions
- Non-Small Cell Lung Cancer
- Interventions
- Canakinumab; Placebo
- Arms
- canakinumab · Experimental
- Placebo · Placebo comparator
- Enrollment
- 1,382
- Primary outcomes
- Disease Free Survival (DFS) by Local Investigator
- Sponsor
- Novartis Pharmaceuticals
- Start
- Mar 16, 2018
- Primary completion
- Mar 17, 2022
- Results posted
- Yes
- Registry record
- NCT03447769 · updated Oct 9, 2024
Publications
linked from the registry- Garon EB, Lu S, Goto Y, De Marchi P, Paz-Ares L, Spigel DR, Thomas M, Yang JC, Ardizzoni A, Barlesi F, Orlov S, Yoshioka H, Mountzios G, Khanna S, Bossen C, Carbini M, Turri S, Myers A, Cho BC. Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial. J Clin Oncol. 2024 Jan 10;42(2):180-191. doi: 10.1200/JCO.23.00910. Epub 2023 Oct 3. PubMed 37788412